ChemicalBook > Product Catalog > Analytical Chemistry > Standard > Pharmaceutical Impurity Reference Standards > 4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine
4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine
4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine Basic information
- Product Name:
- 4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine
- Synonyms:
-
- 4'-Chloro-4,7'-bi-7H-pyrrolo[2,3-d]pyrimidine
- Tofacitinib impurity 21/4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine
- Tofacitinib-27
- 4,7'-Bi-7H-pyrrolo[2,3-d]pyrimidine, 4'-chloro-
- 4-chloro-7-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-7H-pyrrolo[2,3-d]pyrimidine
- Azilsartan medoxomil impurity330
- Tofacitinib Related Compound 29Q: What is Tofacitinib Related Compound 29 Q: What is the CAS Number of Tofacitinib Related Compound 29
- 4'-Chloro-4,7'-bi-7H-pyrrolo[2,3-d]pyrimidine(Tofacitinib impurity )
- CAS:
- 134965-85-8
- MF:
- C12H7ClN6
- MW:
- 270.68
- Mol File:
- 134965-85-8.mol
More
Less
4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine Chemical Properties
- Boiling point:
- 397.4±52.0 °C(Predicted)
- Density
- 1.74±0.1 g/cm3(Predicted)
- pka
- 10.39±0.20(Predicted)
More
Less
4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidineSupplier
BeiJing Hwrk Chemicals Limted
- Tel
- 0757-86329057 18934348241
- sales4.gd@hwrkchemical.com
Wuhan ariel chemical Co., LTD.
- Tel
- 18986259541 18986259541
- sales@3stc.com
Beijing Comparison Pharmaceutical Technology Co., Ltd
- Tel
- 010-010-52878169 15801002657
- sales@bjcomparison.com
Wuhan Kaymke Chemical Co., Ltd.,
- Tel
- 027-027-87342388 18086026008
- sales@kaymke.com
ChemStrong Scientific Co.,Ltd
- Tel
- 0755-0755-66853366 13670046396
- sales@chem-strong.com
More
Less
4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine(134965-85-8)Related Product Information
- 7H-Pyrrolo[2,3-d]pyrimidine, 4-hydrazinyl-
- Tofacitinib impurity T
- 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3-piperidinyl]-
- Tofacitinib Impurity 45
- Ethyl S-4-chloro-3-hydroxybutyrate
- 2-amino-4-fluoro-5-nitrobenzoic acid
- (3R,4R)-N,4-dimethyl-piperidin-3-amine
- (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile
- (S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine
- Tofacitinib Impurity 20
- R-afatinib
- 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
- 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
- Tofacitinib Impurity 19
- 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile
- N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine